Lila Bio, a startup spun out of Nobel laureate David Baker’s UW lab, received a $3.65M NIH grant to develop an AI-designed protein therapy for pulmonary hypertension. Given by injection a few times yearly, it would treat the underlying disease rather than symptoms. Funding covers animal and patient-tissue testing.
Lila Bio Lands $3.65M Grant to Fight Pulmonary Hypertension with AI-Designed Proteins
Share: